Chinese scholars published new results in the treatment of leukemia, semi-matching and portable
July 07, 2017 Source: People's Daily
Window._bd_share_config={ "common":{ "bdSnsKey":{ },"bdText":"","bdMini":"2","bdMiniList":false,"bdPic":"","bdStyle":" 0","bdSize":"16"},"share":{ }};with(document)0[(getElementsByTagName('head')[0]||body).appendChild(createElement('script')) .src='http://bdimg.share.baidu.com/static/api/js/share.js?v=89860593.js?cdnversion='+~(-new Date()/36e5)];Recently, Chinese scholars published the latest research results in the internationally renowned journal "Leukemia", suggesting that semi-consistent donors can also become the first choice for transplantation, opening a new era of leukemia treatment.
The study was completed by the research group of Professor Huang Xiaojun of Peking University Institute of Hematology and Peking University People's Hospital. According to Huang Xiaojun, allogeneic hematopoietic stem cell transplantation is one of the most effective methods for curing hematological malignancies. Human leukocyte antigen (HLA) donors with the same contractor and recipient have always been the first choice, but the probability of sibling coincidence is only 25%. The lack of donors severely restricts the application of transplantation. The team's “Beijing Program†haplotype (ie, semi-match) transplantation system has achieved the same effect as sibling, non-blood and cord blood transplantation, surpassing the chemotherapy effect and solving the lack of donors of hematopoietic stem cell transplantation. problem. (Reporter Bai Jianfeng)
The best choice for Analog hearing aids with earbuds design
The best choice for Analog hearing aids with earbuds design
Shenzhen Sunshine Technology Co.,Ltd , https://www.szyatwin.com